TrialTargeted oncology2025

Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 Study.

Patrick Hanafin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.